Stockreport

Retrophin to Highlight Fosmetpantotenate Program for PKAN at Upcoming Medical Congresses

RETROPHIN INC  (RTRX) 
Last retrophin inc earnings: 2/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.retrophin.com/investor-relations
PDF SAN DIEGO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that presentations highlighting the design of the ongoing pivotal Phase 3 F [Read more]